Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyRichard T. Hoppe, Ndiya Ogba, Ranjana H. Advani et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 153
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in OncologyRichard T. Hoppe, Hema Sundar, Ranjana H. Advani et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 142
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018Richard T. Hoppe, Ndiya Ogba, Ranjana H. Advani et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 63
Hodgkin Lymphoma, Version 2.2015Richard T. Hoppe, Hema Sundar, Ranjana H. Advani et al.|Journal of the National Comprehensive Cancer Network|2015Cited by 53
Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathwayXianwen Peng, Li Zhang, Yongqiang Yang et al.|Biomedicine & Pharmacotherapy|2020Cited by 37